Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Metastatic Hormone Refractory Prostate Cancer × cabozantinib × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Renal Cell 25 Carcinoma, Hepatocellular 4 Urinary Bladder Neoplasms 3 Urethral Neoplasms 3 Prostatic Neoplasms 3 Osteosarcoma 3 Melanoma 3 Kidney Neoplasms 3 Colorectal Neoplasms 3 Clear-cell metastatic renal cell carcinoma 3 Urogenital Neoplasms 2 Ureteral Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Small Cell Lung Carcinoma 2 Sarcoma, Ewing 2 Penile Neoplasms 2 Ovarian Neoplasms 2 Neuroendocrine Tumors 2 Neoplasm Metastasis 2 Carcinoma, Transitional Cell 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma 2 Brain Neoplasms 2 Adrenocortical Carcinoma 2 von Hippel-Lindau Disease 1 Urologic Neoplasms 1 Urachal adenocarcinoma 1 Triple Negative Breast Neoplasms 1 Seminoma 1 Sarcoma, Kaposi 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡